Journal article
Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study
Abstract
IntroductionNovel therapies are emerging for the prevention of chronic kidney disease (CKD) progression in patients with type 2 diabetes (T2D). Within the FOUNTAIN platform (NCT05526157; EUPAS48148), this real-world study aimed to characterize cohorts of adults with CKD and T2D starting therapy with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in Europe, Japan, and the United States (US) during 2012–2021.MethodsThis multinational, …
Authors
Pladevall-Vila M; Ziemiecki R; Johannes CB; Khan AM; Mines D; Ebert N; Kovesdy CP; Thomsen RW; Baak BN; García-Sempere A
Journal
Diabetes Therapy, Vol. 16, No. 5, pp. 931–954
Publisher
Springer Nature
Publication Date
5 2025
DOI
10.1007/s13300-025-01717-8
ISSN
1869-6953